Advances in mesenchymal stem cells combined with traditional Chinese medicine therapy for liver fibrosis.
- Author:
Shu DONG
;
Shibing SU
- Publication Type:Review
- From:
Journal of Integrative Medicine
2014;12(3):147-155
- CountryChina
- Language:English
-
Abstract:
Liver fibrosis is a primary cause of liver cirrhosis, and even hepatocarcinoma. Recently, the usage of mesenchymal stem cells (MSCs) has been investigated to improve liver fibrosis. It has been reported that the differentiation, proliferation and migration of MSCs can be regulated by traditional Chinese medicine treatment; however, the mechanisms are still unclear. In this article, the authors review the characteristics of MSCs such as multidirectional differentiation and homing, and its application in animal experiments and clinical trials. The authors also list areas that need further investigation, andlook at the future prospects of clinical application of MSCs.
